nach oben

Erschienen in:

01.09.2020 | Clinical study

Solid cancer mortality with antithyroid drugs, RAI or surgery

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

In patients with hyperthyroidism, the solid cancer mortality rate does not appear to differ in patients treated with antithyroid drugs (ATD), radioactive iodine (RAI) or surgery after controlling for confounding, according to study results reported in JAMA Network Open, although there is "a dose-dependent association between RAI and solid cancer mortality". …

Kitahara CM, et al. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism. JAMA Network Open : 23 Jul 2020. Available from: URL: https://doi.org/10.1001/jamanetworkopen.2020.9660

Titel: Solid cancer mortality with antithyroid drugs, RAI or surgery
Publikationsdatum: 01.09.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-83365-0

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Solid cancer mortality with antithyroid drugs, RAI or surgery

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Convalescent anti-SARS-CoV-2 plasma

Methylprednisolone

Antineoplastics

Antineoplastics

Quetiapine

Gabapentin